TruWealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
TruWealth Advisors's AMGN Position: Q2 2023 in Review
TruWealth Advisors sold out of Amgen (AMGN) in Q2 2023, closing a stake of 18,940 shares — an estimated $4.58M sold.
TruWealth Advisors first reported a position in AMGN in Q4 2020 and held it in 5 quarters. The position peaked at $4.58M in Q1 2023. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.
- TruWealth Advisors reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
- TruWealth Advisors sold 18,940 Amgen shares in Q2 2023, an estimated $4.58M.
- TruWealth Advisors first reported a position in Amgen in Q4 2020 and held it in 5 quarters.
- TruWealth Advisors's Amgen position peaked at $4.58M in Q1 2023.
- 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.
Based on TruWealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.